These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29235037)

  • 1. Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma.
    Mehrad M; Dupont WD; Plummer WD; Lewis JS
    Head Neck Pathol; 2018 Dec; 12(4):448-454. PubMed ID: 29235037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 7 in Oropharyngeal Squamous Cell Carcinoma: A Junctional Biomarker for Human Papillomavirus-Related Tumors.
    Woods RSR; Keegan H; White C; Tewari P; Toner M; Kennedy S; O'Regan EM; Martin CM; Timon CVI; O'Leary JJ
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):702-710. PubMed ID: 28082347
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers of squamocolumnar junction cells in normal tonsils and oropharyngeal cancer with and without HPV infection.
    Morbini P; Capello GL; Alberizzi P; Benazzo M; Paglino C; Comoli P; Pedrazzoli P
    Histol Histopathol; 2015 Jul; 30(7):833-9. PubMed ID: 25644820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 7 and 19 expression in oropharyngeal and oral squamous cell carcinoma.
    Woods RSR; Callanan D; Jawad H; Molony P; Werner R; Heffron C; Feeley L; Sheahan P
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1435-1443. PubMed ID: 34046748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin7 expression in histologic and cytologic specimens of cystic neck metastasis from HPV positive squamous cell carcinoma of the tonsil: A case report.
    Cho YK; Lee SJ; Woo JJ; Lee H; Lee H
    Diagn Cytopathol; 2018 Apr; 46(4):331-335. PubMed ID: 29048728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV infection in oropharyngeal squamous cell carcinomas: correlation with tumor size.
    Gletsou E; Papadas TA; Baliou E; Tsiambas E; Ragos V; Armata IE; Metaxas GE; Fotiades PP
    J BUON; 2018; 23(2):433-438. PubMed ID: 29745089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous and Neuroendocrine Specific Immunohistochemical Markers in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Study.
    Lewis JS; Chernock RD; Bishop JA
    Head Neck Pathol; 2018 Mar; 12(1):62-70. PubMed ID: 28528398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
    Shankar A; Crouch DH; Macluskey M
    Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
    Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large Cell Neuroendocrine Carcinoma of the Head and Neck: A Clinicopathologic Series of 10 Cases With an Emphasis on HPV Status.
    Thompson ED; Stelow EB; Mills SE; Westra WH; Bishop JA
    Am J Surg Pathol; 2016 Apr; 40(4):471-8. PubMed ID: 26735857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.
    Harbison RA; Kubik M; Konnick EQ; Zhang Q; Lee SG; Park H; Zhang J; Carlson CS; Chen C; Schwartz SM; Rodriguez CP; Duvvuri U; Méndez E
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma.
    Wakisaka N; Yoshida S; Kondo S; Kita M; Sawada-Kitamura S; Endo K; Tsuji A; Nakanish Y; Murono S; Yoshizaki T
    Histopathology; 2015 May; 66(6):771-80. PubMed ID: 25039283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.